Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from SELLAS Life Sciences Group, Inc.’s reported figures.
The source filing: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001390478-26-000008
FAQ
- What is SELLAS Life Sciences Group, Inc.'s EBIT?
- SELLAS Life Sciences Group, Inc. (SLS) reported EBIT of -$9.25M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s EBIT changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s EBIT decreased by 52.6% year-over-year, from -$6.06M to -$9.25M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s EBIT?
- Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s EBIT has grown at a 2.8% compound annual growth rate (CAGR), from -$25.29M to -$28.27M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about SELLAS Life Sciences Group, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude